Ivermectin regulatory update

Last month, FDA accepted for review an NDA from Topaz for 0.5% ivermectin cream to treat head lice. The PDUFA date is Feb. 7, 2012. Ivermectin is a topical broad-spectrum anti-parasitic agent that bin...